Skip to main content

Platelets Secrete an Eosinophil-Chemotactic Cytokine which is a Member of the C-C-Chemokine Family

  • Chapter
The Chemokines

Abstract

Eosinophilic granulocytes (Eos) represent an inflammatory cell type hypothesized to play a crucial role in the development of chronic asthma (1), after allergen challenge in sensitized animals (2) and atopic subjects (3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Frigas, E., G.J. Gleich. 1986. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol.77: 527–537.

    Article  PubMed  CAS  Google Scholar 

  2. Lellouch-Tubiana, A., J. Lefort, M.-T. Simon, A. Pfister, and B.B. Vargaftig. 1988. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Am. Rev. Respir. Dis.137: 948–954.

    PubMed  CAS  Google Scholar 

  3. Leiferman, K. M. 1989. Eosinophils in atopic dermatitis. Allergy44: 20–26.

    PubMed  Google Scholar 

  4. Kay, A.B., H.S. Shin, K.F. Austen. 1973. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). Immunology24: 969–976.

    PubMed  CAS  Google Scholar 

  5. Czarnetzki, B.M., W. König, L.M. Lichtenstein. 1976. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A 23187. J. Immunol.117: 229–234.

    PubMed  CAS  Google Scholar 

  6. Morita, E., J.-M. Schröder, E. Christophers. 1989. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxis. Scand.J.Immunol.29: 709–716.

    Article  PubMed  CAS  Google Scholar 

  7. Wardlaw, A.J., R. Moqbel, O. Cromwell, A.B. Kay. 1986. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest.78: 1701–1712.

    Article  PubMed  CAS  Google Scholar 

  8. Morita, E., J.-M. Schröder, E. Christophers. 1990. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid. J. Immunol.144: 1893–1900.

    PubMed  CAS  Google Scholar 

  9. Schwenk, U., E. Morita, R. Engel, J.-M. Schröder. 1992. Identification of 5-Oxo-15-hydroxy6,8,11,13-eicosatetraenoic acid as a novel and potent human eosinophil chemotactic eicosanoid. J. Biol. Chem.267: 12482–12488.

    PubMed  CAS  Google Scholar 

  10. Wang, J.M., A. Rambaldi, A. Biondi, Z.G. Chen, C.J. Sanderson, A. Mantovani. 1989. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol.19: 701–705.

    Article  PubMed  CAS  Google Scholar 

  11. Warringa, R.A.J., L. Koenderman, P.T.M. Kok, J. Kreukmiet, P.L.B. Bruijnzeel. 1991. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony stimulating factor and interleukin3. Blood 77: 2694–2700.

    PubMed  CAS  Google Scholar 

  12. Kameyoshi, Y., E. Morita, J.-M. Schröder, E. Christophers. 1992. Recombinant human interleukin-3 is a chemoattractant for human eosinophils, but not for neutrophils. Submitted for publication.

    Google Scholar 

  13. Rand, T.H., W.W. Cruikshank, D.M. Center, P.F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med.173: 1521–1528.

    Article  PubMed  CAS  Google Scholar 

  14. Baggiolini, M., A. Walz, S.L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest.84: 1045–1049.

    Article  PubMed  CAS  Google Scholar 

  15. Schall TJ. 1991. Biology of the RANTES/SIS cytokine family. Cytokine3: 165–183.

    Article  PubMed  CAS  Google Scholar 

  16. Schröder, J.-M. 1992. Chemotactic cytokines in the epidermis. Exp. Dermatol.1: 12–19.

    Article  PubMed  Google Scholar 

  17. Schröder, J.-M., U. Mrowietz, E. Morita, E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks Interleukin 1 activity. J. lmmunol.139: 3474–3483.

    Google Scholar 

  18. Yoshimura, T., K. Matsushima, S. Tanaka, E.A. Robinson, E. Appella, JJ. Oppenheim, E.J. Leonard. 1987b. Purification of a human monocyte-derived neutrophil chemotactic factor that shares sequence homology with other host defense cytokines. Proc. Natl. Acad. Sci. USA84: 9233.

    Article  CAS  Google Scholar 

  19. Schröder, J.-M., N. Persoon, E. Christophers. 1990. Lipopolysaccharide-stimulated human monocytes secrete apart from NAP-1/11,8 a second neutrophil-activating protein: NHZ terminal aminoacid sequence-identity with melanoma growth stimulatory activity (MGSA/gro). J. Exp. Med.171: 1091–1100.

    Article  PubMed  Google Scholar 

  20. Moser, B., I. Clark-Lewis, R. Zwahlen, M. Baggiolini. 1990. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J. Exp. Med.171: 1797–1802.

    Article  PubMed  CAS  Google Scholar 

  21. Walz, A., B. Dewald, V. von Tschamer, M. Baggiolini. 1989. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III, and platelet factor 4 on human neutrophils. J. Exp. Med.170: 1745–1750.

    Article  PubMed  CAS  Google Scholar 

  22. Yoshimura, T., N. Yuhki, S.K. Moore, E. Appella, M.I. Lerman, E.J. Leonard. 1989. Human monocyte chemoattractant protein-1 (MCP-1): Full-length cDNA cloning, expression in mitogenstimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244: 487–493.

    Article  PubMed  CAS  Google Scholar 

  23. Deuel, T.F., R.M. Senior, D. Chang, D.L. Griffin, R.L. Heinrikson, E.T. Kaiser. 1981. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc. Natl. Acad. Sci. USA78: 4584–4587.

    Article  PubMed  CAS  Google Scholar 

  24. Schröder, J.-M., M. Sticherling, N.-L. M. Perssoon, E. Christophers. 1990. Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet factor 4. Biochem. Biophys. Res. Commun.172: 898–904.

    Article  PubMed  Google Scholar 

  25. Castor, C.W., J.W. Miller, D.A. Walz. 1983. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc. Natl. Acad. Sci. USA80: 765–769.

    Article  PubMed  CAS  Google Scholar 

  26. Kameyoshi, Y., A. Dörschner, A.I. Mallet, E. Christophers, J.-M. Schröder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med.176: 587–592.

    Article  PubMed  CAS  Google Scholar 

  27. Chignard, M., J.P. Le Conedic, B.B. Vargaftig, J. Benveniste. 1980. Platelet-activating factor (PAF- acether) secretion from platelets: effect of aggregating agents. Br. J. Haematol.46: 455–464.

    Article  PubMed  CAS  Google Scholar 

  28. Schall, Ti., J. Jongstra, Bi. Dyer, J. Jorgensen, C. Claylberger, M.M. Davis, A.M. Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol.141: 1018–1025.

    PubMed  CAS  Google Scholar 

  29. Schall, Ti., K. Bacon, K.J. Toy, D.V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (Lond.)347: 669–671.

    Article  CAS  Google Scholar 

  30. Leiferman, K.M. 1991. A current perspective on the role of eosinophils in dermatologic diseases. J. Am. Acad. Dermatol.24: 1101–1112.

    Article  PubMed  CAS  Google Scholar 

  31. Page, C.P. 1989. Platelets as inflammatory cells. Immunopharmacology17: 51–59.

    Article  PubMed  CAS  Google Scholar 

  32. Coyle, Ai., C.P. Page, L. Atkinson, R. Flanagan, W.J. Metzger. 1990. The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and hieghtened airway responsiveness in allergic rabbits. Am. Rev. Respir. Dis.142: 587–593.

    Article  PubMed  CAS  Google Scholar 

  33. Knauer, K.A., L.M. Lichtenstein, N.F. Adkinson, Jr., and I.F. Fish. 1981. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N. Engl. J. Med.304: 1404–1407.

    Article  PubMed  CAS  Google Scholar 

  34. Gresele, P., S. Grasselli, T. Todisco, and G.G. Nenci. 1985. Platelets and asthma. Lancet, ii: 347.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schröder, JM., Kameyoshi, Y., Christophers, E. (1993). Platelets Secrete an Eosinophil-Chemotactic Cytokine which is a Member of the C-C-Chemokine Family. In: Lindley, I.J.D., Westwick, J., Kunkel, S. (eds) The Chemokines. Advances in Experimental Medicine and Biology, vol 351. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2952-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2952-1_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6283-8

  • Online ISBN: 978-1-4615-2952-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics